(IN BRIEF) TreeFrog Therapeutics has secured €30 million in financing from the European Investment Bank to advance its cell therapy program for Parkinson’s disease and support the development of its internal pipeline targeting diseases with high unmet needs. The funding, … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged 3D microtissues, bioreactors, C-Stem, cell therapy, dilutive financing, EIB, European Investment Bank, Healthcare Innovation, InvestEU, iPSCs, Microfluidics, Parkinson's disease, partnership, Regenerative medicine, stem cell biology, sustainability, TreeFrog Therapeutics, venture debt, €30 million financing
(PRESS RELEASE) HELSINKI, 30-Nov-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland, and University Hospital Helsinki, Finland’s largest provider of healthcare services, have announced that their researchers have developed a method to … Read the full press release
Posted in Education, Finland, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged autologous cells, autologous pluripotent stem cells, Biomedicum Helsinki Stem Cell Center, corrected stem cells, CRISPR-Cas9, DNA errors, gene alterations, gene editing, gene scissors, genetic alterations, genetic diseases, immunological challenges, iPSCs, Joonas Sokka, Kirmo Wartiovaara, Ras Trokovic, researchers, Rocío Maldonado, Sami Jalil, skin biopsy, Stem cells, therapies, Timo Keskinen, Timo Otonkoski, University Hospital Helsinki, University of Helsinki
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?